Managing Partner
Prior to joining Bioqube, Jon Edwards was a managing director at Red Tree Venture Capital and part of the founding team where he served on the investment committee. He was also a partner and founding team member at Medicxi based in their London office. Jon began his venture capital career at Index Ventures in Switzerland. Before moving to Europe, Jon was a life sciences strategy consultant at ClearView Healthcare Partners based in Boston. Jon’s investments at Red Tree included Bicara Therapeutics, Rondo Therapeutics, Excellergy, Biograph55 and Sardona Therapeutics. His previous investments include Synthorx (acquired by Sanofi), Phathom Pharmaceuticals, Checkmate Pharmaceuticals (acquired by Regeneron), Impact Biomedicines (acquired by Celgene), Sydnexis, Xenikos and Breakpoint Therapeutics. He has also held board seats on Z-Factor, UltraHuman and Palladio Biosciences and was a board observer with ApcinteX and Capella Bioscience. Jon currently serves on the Bicara board as an observer and as a director at Synox Therapeutics. He also acts as a non-executive director at RxCellerate, a U.K. based contract research organization.